These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 1813853

  • 1. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [Abstract] [Full Text] [Related]

  • 2. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
    [Abstract] [Full Text] [Related]

  • 3. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I, Balázs C.
    Orv Hetil; 1991 Sep 22; 132(38):2097-100. PubMed ID: 1923482
    [Abstract] [Full Text] [Related]

  • 4. IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves' disease.
    Molnár I, Kaczur V, Boros A, Krajczár G, Balázs C.
    J Endocrinol Invest; 1995 Jun 22; 18(6):408-14. PubMed ID: 7594233
    [Abstract] [Full Text] [Related]

  • 5. Cellular and humoral autoimmune responses against human eye muscle membrane antigen in Graves' disease.
    Molnár I, Németi K, Bokk A, Stenszky V, Balázs C, Farid NR.
    Acta Med Hung; 1990 Jun 22; 47(1-2):43-51. PubMed ID: 2280995
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K, Metcalfe R, Weetman AP.
    J Clin Endocrinol Metab; 1995 Dec 22; 80(12):3430-7. PubMed ID: 8530579
    [Abstract] [Full Text] [Related]

  • 7. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.
    J Clin Endocrinol Metab; 2000 Apr 22; 85(4):1641-7. PubMed ID: 10770210
    [Abstract] [Full Text] [Related]

  • 8. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M, Bingoye F, Chung F, Wall JR.
    J Clin Endocrinol Metab; 1988 May 22; 66(5):939-45. PubMed ID: 3360902
    [Abstract] [Full Text] [Related]

  • 9. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
    Ohkura T, Taniguchi S, Yamada K, Nishio N, Okamura T, Yoshida A, Kamijou K, Fukata S, Kuma K, Inoue Y, Hisatome I, Senju S, Nishimura Y, Shigemasa C.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):432-40. PubMed ID: 15358194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-2 receptor in sera of patients with Graves' disease.
    Balázs C, Farid NR.
    Acta Med Hung; 1991 Aug 20; 48(1-2):3-11. PubMed ID: 1813855
    [Abstract] [Full Text] [Related]

  • 13. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW, Hiromatsu Y, Laryea E, Wosu L, How J, Wall JR.
    J Clin Endocrinol Metab; 1986 Aug 20; 63(2):316-22. PubMed ID: 3755139
    [Abstract] [Full Text] [Related]

  • 14. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
    Tandon N, Yan SL, Arnold K, Metcalfe RA, Weetman AP.
    Clin Endocrinol (Oxf); 1994 May 20; 40(5):629-39. PubMed ID: 8013144
    [Abstract] [Full Text] [Related]

  • 15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A, Perrino S, Coronella C, Sansone D, Ruocco G, Tirelli G, Di Martino S, Conte M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2004 Jun 20; 60(6):694-8. PubMed ID: 15163332
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.
    Faryna M, Nauman J, Gardas A.
    Br Med J (Clin Res Ed); 1985 Jan 19; 290(6463):191-2. PubMed ID: 3917747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G, Grübl M, Moncayo R, Schilling S, Weber P, Beyer J, Krause U.
    Dev Ophthalmol; 1989 Jan 19; 20():68-78. PubMed ID: 2574117
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.